Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial - E4599 [abstract LBA4] - Sandler,A.; Gray,R.; Brahmer,J. (Proc Am Soc Clin Oncol, 2005)